[HTML][HTML] The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis

L Zhang, Y Liang, S Li, F Zeng, Y Meng, Z Chen, S Liu… - Molecular cancer, 2019 - Springer
Peripheral circulating free DNA (cfDNA) is DNA that is detected in plasma or serum fluid with
a cell-free status. For cancer patients, cfDNA not only originates from apoptotic cells but also …

The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis.

L Zhang, Y Liang, S Li, F Zeng, Y Meng, Z Chen… - Molecular …, 2019 - go.gale.com
Peripheral circulating free DNA (cfDNA) is DNA that is detected in plasma or serum fluid with
a cell-free status. For cancer patients, cfDNA not only originates from apoptotic cells but also …

The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis

L Zhang, Y Liang, S Li, F Zeng, Y Meng… - Molecular …, 2019 - search.proquest.com
Peripheral circulating free DNA (cfDNA) is DNA that is detected in plasma or serum fluid with
a cell-free status. For cancer patients, cfDNA not only originates from apoptotic cells but also …

The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis

L Zhang, Y Liang, S Li, F Zeng, Y Meng, Z Chen… - Molecular …, 2019 - hero.epa.gov
Peripheral circulating free DNA (cfDNA) is DNA that is detected in plasma or serum fluid with
a cell-free status. For cancer patients, cfDNA not only originates from apoptotic cells but also …

[PDF][PDF] The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis

L Zhang, Y Liang, S Li, F Zeng, Y Meng, Z Chen, S Liu… - 2019 - scholar.archive.org
Peripheral circulating free DNA (cfDNA) is DNA that is detected in plasma or serum fluid with
a cell-free status. For cancer patients, cfDNA not only originates from apoptotic cells but also …

The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis.

L Zhang, Y Liang, S Li, F Zeng, Y Meng… - Molecular …, 2019 - search.ebscohost.com
Peripheral circulating free DNA (cfDNA) is DNA that is detected in plasma or serum fluid with
a cell-free status. For cancer patients, cfDNA not only originates from apoptotic cells but also …

[HTML][HTML] The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis

L Zhang, Y Liang, S Li, F Zeng, Y Meng, Z Chen… - Molecular …, 2019 - ncbi.nlm.nih.gov
Peripheral circulating free DNA (cfDNA) is DNA that is detected in plasma or serum fluid with
a cell-free status. For cancer patients, cfDNA not only originates from apoptotic cells but also …

The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis

L Zhang, Y Liang, S Li, F Zeng, Y Meng… - Molecular …, 2019 - pubmed.ncbi.nlm.nih.gov
Peripheral circulating free DNA (cfDNA) is DNA that is detected in plasma or serum fluid with
a cell-free status. For cancer patients, cfDNA not only originates from apoptotic cells but also …

[HTML][HTML] The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis

L Zhang, Y Liang, S Li, F Zeng… - Molecular …, 2019 - molecular-cancer.biomedcentral …
Peripheral circulating free DNA (cfDNA) is DNA that is detected in plasma or serum fluid with
a cell-free status. For cancer patients, cfDNA not only originates from apoptotic cells but also …

The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis.

L Zhang, Y Liang, S Li, F Zeng, Y Meng, Z Chen… - Molecular …, 2019 - europepmc.org
Peripheral circulating free DNA (cfDNA) is DNA that is detected in plasma or serum fluid with
a cell-free status. For cancer patients, cfDNA not only originates from apoptotic cells but also …